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Abstract 
The decarboxylative Claisen rearrangement of a range of substituted diallyl 2-sulfonylmalonates is 
described. The reaction displays a very high degree of regioselectivity, with allylic substituents 
possessing electron-rich substituents at the 3-position rearranging preferentially. The substrates are 
made by C-carboxylation of the corresponding allyl sulfonylacetates with allyl para-nitrophenyl 
carbonates. In one instance, the presence of a highly electron-withdrawing side-chain led to the 
competing formation of a γ-lactone by-product. 
 
The Claisen rearrangement continues to be the focus of considerable research effort.
[1]
 Since its 
introduction in 1972,
[2]
 the Ireland silyl ketene acetal variant in particular has been widely used in 
complex target-oriented synthesis.
[3]
 This modified process benefits from the ease of preparation of 
the ketene acetal substrates and the relatively mild conditions for the sigmatropic rearrangement. In 
addition, it enables overall C-allylation of carboxylic acids using allylic alcohols as the surrogate 
electrophiles, with regiospecific allylic double-bond transposition. We recently reported
[4,5]
 a novel 
variant of the Ireland-Claisen rearrangement reaction in which α-tosyl silyl keteneacetals formed in 
situ from allylic tosylacetates 1 in the presence of N,O-bis(trimethylsilyl)acetamide (BSA) and 
 2 
potassium acetate undergo thermally-induced [3,3]-sigmatropic rearrangement followed by acetate-
induced desilylation-decarboxylation to provide homoallylic sulfones 2 in a single step.
[6,7]
 
Furthermore, we have subsequently shown
[8]
 that introduction of an additional electron-
withdrawing α-substituent enables malonyl substrates 3 to undergo this decarboxylative Claisen 
rearrangement (dCr) to provide α-carboxyhomoallyl sulfones 4 at ambient temperature (Scheme 1). 
 We became interested in the properties of fully bifunctional 2-tolylsulfonylmalonyl dCr 
substrates such as 5. These diallyl esters are in principle able to undergo two dCr reaction cycles 
within the same molecule. We reasoned that dCr substrates such as 5 would be induced to form 
“monorearrangement” products 6 when subjected to the mild reaction conditions shown to be 
effective for substrates 3 (Scheme 2). Further reaction of 6 was not expected, since although 
sulfonylacetates 6 are themselves substrates for a second dCr reaction cycle, they lack the additional 
electron-withdrawing α-substituent necessary for reaction at ambient temperature. Intramolecular 
competition experiments have been reported previously
[9,10,11,12,13]
 for the Claisen and related 
rearrangements. However, the substrates utilised possessed a single ester grouping, which was 
derived from a doubly-allylic secondary alcohol. Additionally, competition in the decarboxylative 
variant has not been studied to date. 
Previously,
[8]
 2-tolylsulfonylmalonate dCr substrates 3 were synthesised by sulfonylation of 
the corresponding malonates with tosyl fluoride under basic conditions at high concentration. In this 
instance, not all desired dCr substrates 5 were accessible by this route. Therefore we adopted an 
alternative synthetic approach, employing para-nitrophenyl carbonates 7 for the C-carboxylation of 
tosylacetates 1, to provide diallyl 2-sulfonylmalonates 5 (Scheme 3, Table 3). Both coupling 
partners 1 and 7 were readily synthesised from the requisite allyl alcohols and commercially-
available starting materials (Schemes 4 & 5, Tables 1 & 2). This carboxylation methodology has 
been shown to be applicable to a variety of R-groups. However, when a highly electron-
withdrawing R-group was employed, in addition to the expected product 5g, the formation of γ-
lactone 11 was observed. (Scheme 6). The structure of this by-product has been confirmed by X-ray 
 3 
crystallography
[14]
 (Figure 1). Lactone 11 is presumed to arise from intramolecular Michael addition 
of the 2-sulfonylmalonyl enolate to the para-nitrostyryl group. 
With a variety of dCr substrates 5 in hand, we undertook the study of their rearrangement 
behaviour. Substrate 5b underwent smooth dCr reaction at 25 °C in 2 h, furnishing in high yield a 
diastereomeric mixture (ca. 1:1) of rearrangement products 6b as a single regioisomer (Scheme 7). 
That the products were those of methoxycinnamyl sidechain rearrangement was confirmed by X-ray 
crystallographic analysis
[14,15]
 of one of the diastereomers (Figure 2). Encouraged by this complete 
regioselectivity, we explored the rearrangement reactions of substrates 5a and 5c–h (Scheme 2). 
The results are shown in Table 4. 
Several features of these results merit comment. Foremost, the remarkable regioselectivity 
observed for substrate 5b operates for many of the other substrates also. The only substrates for 
which total regioselectivity was not observed were 5d and 5g. In these instances the phenyl-
substituted side chain was the more reactive, as determined from the product ratios (6d:6d’ and 
6g:6g’ were both 3:1). Overall, a pronounced preference for the reaction of electron-rich side-chains 
was observed. The most reactive substrate was 5a, which possesses the most electron-rich allyl 
groups; this was converted into 6a in near-quantitative yield at 0 °C. As indicated in Table 4, 
substrates with less electron-rich side chains required higher reaction temperatures and longer 
reaction times, and yields of 6 were lower. In the most extreme instance, substrate 5h was found to 
be inert to the previous reaction conditions, and use of microwave irradiation was necessary to 
induce  rearrangement, giving 6h in modest yield. 
It seems likely that dCr reaction selectivity is influenced by steric as well as electronic factors. 
For example, the unexpected skipped diene product 5c, in which conjugative stabilization has been 
lost, may arise from the less sterically congested of the two possible regioisomeric transition states. 
The electronic effect is demonstrated unambiguously by substrates 5b and 5g, in which differing 
aryl para- substituents are distant from the reactive array and therefore will not sterically influence 
the regioselectivity.  We are currently engaged in a quantitative kinetic study of these effects. A 
 4 
comparison of 6e, 6f and 6g suggests the non-reacting side-chain is a determinant of yield (as all 
three products share the same reacting side-chain). However, variation in yield may simply be due 
to harsher reaction conditions degrading the substrate/catalyst, or inherent instability of the 
substrate itself (6g, c.f. 11). The results in Table 4 permit the side-chains to be ranked in order of 
reactivity, as shown in Scheme 8. 
The regioselectivity observed for substrates 5f and 5h initially seems anomalous. If the diene 
side-chain in 5c is more reactive than a phenyl-substituted side-chain, one might expect the enyne 
side-chain in 5f and 5h to react in preference to a phenyl-substituted or unsubstituted side-chain, 
respectively. However, this was not observed. The alkyne itself is sterically insignificant and we 
ascribe the lack of reactivity to the trimethylsilyl group instead – the electron-withdrawing nature of 
silicon biases the electronic distribution so as to disfavour reaction. 
A precedent does exist for rate enhancement in the Ireland–Claisen rearrangement with an 
electron-donating substituent in the C6 position – Curran has shown
[16]
 that the presence of an 
oxygen in this position leads to a rate acceleration effect of one or more orders of magnitude. This 
effect (which has been studied computationally
[17]
) is rationalized as a “vinylogous anomeric” 
(π→σ*) stabilization[16d,18] of the transition state, in that weakening of the O3–C4 bond facilitates its 
cleavage upon going to an early transition state
[19,20]
 in which bond-breaking may be
[21]
 significantly 
more advanced than bond-making (Scheme 9). The observations that an oxygen at the C4 position 
leads to a similar rate acceleration
[16e]
 and that solvent effects
[16e,20c]
 and H-bonding additives
[16f]
 are 
significant further support the idea of a dipolar transition state. Such an argument could equally be 
applied to our substrates 5a-b, albeit with the conjugated oxygen further removed from the reactive 
array. However, our results demonstrate that the effect is by no means limited to oxygen, or indeed 
any heteroatom; any electron-donating substituent confers enhanced reactivity. 
In summary, electronic selectivity of the decarboxylative Claisen rearrangement in 
bifunctional substrates has been demonstrated. Current studies in our laboratory are directed 
towards effecting the double rearrangement of diallyl 2-sulfonylmalonates 5 and employing the 
 5 
resultant dienes in the synthesis of carbocyclic and heterocyclic natural and unnatural products. The 
results of these investigations will be reported in due course.  
 
Supporting Information 
Full experimental details and spectroscopic information are provided for all novel compounds (1a-
g, 5a-h, 6a-h, 7a,d). 
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Scheme 1 Synthesis of homoallylic sulfones by the decarboxylative Claisen rearrangement. 
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Scheme 2 Reaction of diallyl 2-sulfonylmalonates. 
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Scheme 3 Synthesis of 2-sulfonylmalonates by C-carboxylation. 
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Scheme 4 Synthesis of allyl tosylacetates. 
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Scheme 5 Synthesis of p-nitrophenylcarbonates. 
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Scheme 6 Unexpected γ-lactone byproduct formation 
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Scheme 7 Total regioselectivity was observed in the dCr reaction. 
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Scheme 8 Order of reactivity for side-chains in dCr reaction. 
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Scheme 9 Proposed vinylogous anomeric effect for 6-oxy substituents. 
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NO2
 
Product R
1
  Yield  
1a 
 
76% 
1b  87% 
1c Ph 71% 
1d Et 91% 
1e H 92% 
1f 
 
94% 
1g 
 
65% 
Table 1 Yields of allyl tosylacetates 
 
 
Product R
1
  Yield  
7a 
 
76% 
7b Ph 86% 
7c H 91% 
7d 
 
75% 
Table 2 Yields of p-nitrophenylcarbonates 
 
OMe
SiMe3
SiMe3
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NO2
 
Product 
R
1
 (Tosylacetate 
fragment) 
R
2
 (p-nitrophenyl 
fragment) 
Yield 
5a 
 
 
16% 
5b 
 
Ph 39% 
5c  Ph 30% 
5d Et Ph 46% 
5e H Ph 56% 
5f Ph 
 
2% 
5f 
 
Ph 28% 
5g 
 
Ph 23%, also 35% 11 
5h 
 
H 17% 
Table 3 Yields of 2-sulfonylmalonates 
 
SiMe3
OMe
SiMe3
SiMe3
OMe
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Substrate Product Conditions Yield 
5a 
6a CH2Cl2, 0 
°C, 2 h, 
1.0eq. BSA, 
0.1eq. 
KOAc 
95% 
5b 
6b CH2Cl2, 25 
°C, 2 h, 
1.0eq. BSA, 
0.1eq. 
KOAc 
81% 
5c 
 
6c 
CH2Cl2, 25 
°C, 16 h, 
1.0eq. BSA, 
0.1eq. 
KOAc 
79% 
5d 
6d 
PhMe, 55 
°C, 4 h, 
2.0eq. BSA, 
0.1eq. 
KOAc 
84% 
5e 
6e PhMe, 
reflux, 16 h, 
2.0eq. BSA, 
0.1eq. 
KOAc 
66% 
5f 
6f CH2Cl2, 25 
°C, 16 h, 
1.0eq. BSA, 
0.1eq. 
KOAc 
82% 
5g 
O
O
Ts
Ph
O
O
Ts
Ph
NO2
NO2
+
3:1
6g 
CH2Cl2, 25 
°C, 16 h, 
1.0eq. BSA, 
0.1eq. 
KOAc 
29% 
5h 
6h CH2Cl2, μw, 
130 °C, 5 
min, 2.0eq. 
BSA, 
0.1eq. 
KOAc 
26% 
Table 4 Products formed in dCr reactions
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O
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OEt Ph
O
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3 : 1
O
O
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O
O
Me3Si
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O
O
Me3Si Ts
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Figure 1 The molecular structure of 11 
 
 
Figure 2 The molecular structure of 6b 
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SUPPORTING INFORMATION TO BE PUBLISHED ELECTRONICALLY 
 
General Laboratory Procedures 
 
 All reactions were performed under nitrogen unless otherwise stated. Melting 
points were determined using Stuart Scientific SMP1 melting point apparatus and are 
uncorrected. Infrared spectra were recorded on a Mattson 5000 FTIR spectrometer. 
Proton magnetic resonance (
1
H NMR) spectra and carbon magnetic resonance (
13
C 
NMR) spectra were recorded on a Brüker DRX-300, a Brüker DRX-400, a Brüker 
Avance 400 or a Brüker AM500 spectrometer. Chemical shifts are in parts per million 
(ppm) and are referenced relative to the residual proton-containing solvent (
1
H NMR: 
7.27 ppm for CDCl3; 
13
C NMR: 77.0 ppm for CDCl3). Mass spectra (CI, FAB, ESI) were 
recorded using VG-7070B, VG707E, VG Autospec Q, Brüker Apex II FTICR or Jeol 
SX-102 instruments. Elemental analyses were performed at the microanalytical 
laboratory of Dr. Stephen Boyer, London Metropolitan University or by Exeter 
Analytical Ltd, Brunel Science Park, Uxbridge. Analytical thin layer chromatography 
(TLC) was performed on precoated aluminium-backed Merck Kieselgel 60 F254 plates. 
Visualisation was effected with ultraviolet light or potassium permanganate. Flash 
chromatography was performed using BDH (40–63 μm) silica gel. Standard solvents 
were distilled under nitrogen prior use; Et2O from sodium-benzophenone ketyl, CH2Cl2 
from CaH, toluene from sodium. Petrol refers to the fraction bp760 40–60 
o
C. DMF was 
supplied by Fluka, >99.5% pure, over molecular sieves (<0.005% H2O). Potassium 
acetate was oven-dried at 120 °C for several days prior to use. N,O-
bis(trimethylsilyl)acetamide was handled under nitrogen. Sodium hydride was a 60% 
w/w dispersion in mineral oil. Microwave reactions were performed in a Biotage 
Initiator. 
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Monoesters (1) 
 
 
Monoester 
(yield) 
Structure
 
 
1a (76%) 
 
1b (87%) 
 
1c (71%) 
 
1d (91%) 
 
1e (92%) 
 
1f (94%) 
 
1g (65%) 
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O
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O
O
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O
O
Ts
O
O
Ts
NO2
O
O
Ts
TMS
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General procedure (1) for the synthesis of (p-Toluenesulfonyl)acetic acid allyl esters 
(1a-g) 
To desired 3-substituted allyl alcohol (1.0 equiv) under N2 was added tosylacetic acid 
(1.0 equiv) in CH2Cl2 (0.2 M). The reaction mixture was cooled to 0 °C and N,N’-
diisopropylcarbodiimide (1.0 equiv) was added via syringe. The reaction mixture was 
stirred at 0 °C for 1 h then at rt for 15 h or until TLC indicated reaction completion. The 
reaction mixture was filtered and concentrated under reduced pressure. Chromatography 
(EtOAc-petrol) afforded the (p-toluenesulfonyl)acetic acid allyl ester in good yield. 
 
(E)-4-Methoxycinnamyl (toluene-4-sulfonyl)acetate 1a: p-Methoxycinnamyl alcohol 
(4.59 g, 28.0 mmol), p-toluenesulfonylacetic acid (5.99 g, 28.0 mmol) and N,N’-
diisopropylcarbodiimide (4.38 ml, 28.0 mmol) in CH2Cl2 (140 ml) were employed in 
general procedure 1. Chromatography (35:65 EtOAc:petrol) gave 1a (7.66 g, 76%) as a 
white crystalline solid; m. pt. 81 °C; Rf 0.59 (50:50 EtOAc:petrol); max (film) 3033, 
2941, 2839, 1739, 1606, 1512, 1456, 1400, 1327, 1275, 1250, 1177, 1149, 1084, 1032, 
966, 843, 814, 727, 646 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 2.41 (s, 3H, Ts-
CH3), 3.84 (s, 3H, -O-CH3), 4.14 (2H, s, -SO2-CH2-), 4.73 (d, 
3
JH,H = 6.5 Hz, 2H, -O-
CH2-), 6.02 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ar-CH=CH-), 6.57 (d,  
3
JH,H = 16.0 Hz, 1H, Ar-
CH=), 6.89 (d, 
3
JH,H = 8.5 Hz, 2H, o-MeO-Ar), 7.28-7.33 (m, 4H, other Ar-H), 7.82 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.7 (Ts-CH3), 
55.3 (-O-CH3),  61.2 (-SO2-CH2-), 67.0 (-O-CH2-), [114.1, 119.3, 128.0, 128.7 and 129.8] 
(3°), 130.6 (4°), 135.3 (3°), [135.7, 145.4, 159.9 and 162.4] (4°); m/z (CI) 378 [M+NH4]
+
, 
352, 314, 236, 224, 188, 147, 121 (Found: [M+NH4]
+
, 378.1379. C19H20O5S requires 
[M+NH4]
+
, 378.1375) (Found: C, 63.37; H, 5.70. C19H20O5S requires C, 63.32; H, 
5.59%). 
  
 
(2E,4E)-Hexa-2,4-dienyl (toluene-4-sulfonyl)acetate (1b): (2E,4E)-Hexa-2,4-dien-1-ol 
(1.96 g, 20 mmol), p-toluenesulfonylacetic acid (4.29 g, 20 mmol) and N,N’-
diisopropylcarbodiimide (3.13ml, 20 mmol) were employed in general procedure 1. 
Chromatography (30:70 EtOAc:petrol) gave 1b (5.12 g, 87%) as a yellow oil; Rf 0.18 
(20:80 EtOAc:petrol); max (film) 3005, 2941, 1741, 1703, 1597, 1446, 1440, 1381, 1329, 
1304, 1277, 1151, 1086, 991, 814, 727, 646 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 
1.73 (d, 
3
JH,H = 6.5 Hz, 3H, =CH-CH3), 2.40 (s, 3H, Ts-CH3), 4.52 (d, 
3
JH,H = 6.5 Hz, 2H, 
-O-CH2-), [5.38-5.48 and 5.67-5.75] (m, 2H, other olefinic H), 5.97 (dd, 
3
JH,H = 15.0, 
 20 
10.5 Hz, 1H, -O-CH2-CH=CH-CH=), 6.15 (dd, 
3
JH,H = 15.0, 10.5 Hz, 1H, -O-CH2-
CH=CH-CH=), 7.31 (d, 
3
JH,H = 8.0 Hz, 2H, m-SO2-Ar), 7.77 (d, 
3
JH,H = 8.0 Hz, 2H, o-
SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 18.2 (=CH-CH3), 21.7 (Ts-CH3), 61.0 
(-SO2-CH2-COO-), 66.6 (-O-CH2-), [122.2, 128.6, 129.8, 130.2 and 131.9] (3°), 135.7 
(4°), 135.9 (3 °C), 145.4 (4°), 162.3 (C=O); m/z (CI) 606 [2M+NH4]
+
, 312 [M+NH4]
+
, 
188, 115, 98, 81, 64 (Found: [M+NH4]
+
, 312.1265. C15H18O4S requires [M+NH4]
+
, 
312.1263).  
 
 
Cinnamyl (toluene-4-sulfonyl)acetate (1c): Cinnamyl alcohol (2.68 g, 20 mmol), p-
toluenesulfonylacetic acid (4.29 g, 20.0 mmol) and N,N’-diisopropylcarbodiimide (3.13 
ml, 20 mmol) were employed in general procedure 1. Chromatography (1:99 
Et2O:CH2Cl2) gave 1c (4.72 g, 71%) as a waxy white solid; m. pt. 42-44 °C; Rf 0.51 (5:95 
Et2O:CH2Cl2); max (film) 3028, 2944, 1741, 1597, 1495, 1448, 1400, 1379, 1327, 1275, 
1151, 1086, 968, 912, 814, 737, 694, 648 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 
2.35 (s, 3H, Ts-CH3), 4.17 (s, 2H, -SO2-CH2-), 4.72 (d, 
3
JH,H = 6.5 Hz, 2H, -O-CH2-), 
6.12 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ph-CH=CH-), 6.59 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 
7.26-7.35 (m, 7H, other Ar-H), 7.82 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 
MHz, CDCl3, 25°C): δ = 21.7 (Ts-CH3), 61.1 (-SO2-CH2-), 66.7 (-O-CH2-), [121.7, 
126.7, 128.4, 128.6, 128.7, 129.9 and 135.3] (3°), [135.6, 135.9 and 145.4] (4°), 162.4 
(C=O); m/z (CI) 678 [2M+NH4]
+
, 464, 348 [M+NH4]
+
, 233, 188, 134 [C9H10O]
+
, 117 
[C9H9]
+
, 64 (Found: [M+NH4]
+
, 348.1273 C18H18O4S requires [M+NH4]
+
, 348.1270)  
 
 
(E)-Pent-2-enyl (toluene-4-sulfonyl)acetate (1d): (E)-2-penten-1-ol (431 mg, 5.0 
mmol), p-toluenesulfonylacetic acid (1.07 g, 5.0 mmol) and N,N’-
diisopropylcarbodiimide (0.79 ml, 5.0 mmol) in CH2Cl2 (20 ml) were employed in 
general procedure 1. Chromatography (10:90 EtOAc:petrol) gave 1d (1.29 g, 91%) as a 
colourless oil; Rf 0.21 (10:90 EtOAc:petrol); max (film) 2964, 2875, 1741, 1597, 1456, 
1400, 1381, 1329, 1277, 1153, 1086, 1018, 970, 814, 727, 646 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3, 25°C): δ = 0.99 (t, 
3
JH,H = 7.5 Hz, 3H, -CH2-CH3), 2.01-2.09 (m, 2H, -CH2-CH3), 
2.45 (s, 3H, Ts-CH3), 4.11 (s, 2H, -SO2-CH2-), 4.51 (d, 
3
JH,H = 6.5 Hz, 2H, -O-CH2-), 
5.38-5.48 (m, 1H, -O-CH2-CH=), 5.74-5.81 (m, 1H, =CH-CH2-CH3), 7.36 (d, 
3
JH,H = 8.0 
Hz, 2H, m-SO2-Ar) 7.81 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 
25°C): δ = 13.0 (=CH-CH2-CH3), 21.7 (Ts-CH3), 25.2 (-CH2-CH3), 61.1, 67.0, 121.6, 
 21 
128.6, 129.8, 135.8, 139.3, 145.4, 162.3 (C=O); m/z (CI) 300 [M+NH4]
+
, 232, 188 
(Found: [M+NH4]
+
, 300.1260. C14H18O4S requires [M+NH4]
+
 300.1270) (Found: C, 
59.35; H, 6.29. C14H18O4S requires C, 59.55; H, 6.43%). 
 
 
Allyl (toluene-4-sulfonyl)acetate (1e): Allyl alcohol (1.36 ml, 20 mmol), p-
toluenesulfonylacetic acid (4.29 g, 20 mmol) and N,N’-diisopropylcarbodiimide (3.13 ml, 
20 mmol) were employed in general procedure 1. Chromatography (35:65 EtOAc:petrol) 
gave 1e (4.67 g, 92%) as a white solid; m. pt. 41 °C; Rf 0.49 (50:50 EtOAc:petrol); max 
(film) 3005, 2947, 1739, 1649, 1597, 1495, 1450, 1400, 1361, 1327, 1292, 1151, 1086, 
989, 935, 814, 729, 646 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 2.44 (s, 3H, Ts-
CH3), 4.12 (s, 2H, -SO2-CH2-), 4.56 (d, 
3
JH,H = 5.5 Hz, 2H, -O-CH2-), 5.20-5.30 (m, 2H, 
-CH=CH2), 5.73-5.83 (m, 1H, -CH=CH2), 7.35 (d, 
3
JH,H = 8.0 Hz, 2H, m-SO2-Ar), 7.80 
(d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.7 (Ts-CH3), 
61.0 (-SO2-CH2-), 66.7 (-O-CH2-), [119.4, 128.6, 129.9 and 130.9] (3°), [135.8 and 
145.5] (4°), 162.2 (C=O); m/z (CI) 272 [M+NH4]
+
, 255 [MH]
+
, 174, 155, 139, 108, 93, 
91, 58 (Found: [M+NH4]
+
, 272.0969. C12H14O4S requires [M+NH4]
+
, 272.0957) (Found: 
C, 56.63; H, 5.81. C12H14O4S requires C, 56.68; H, 5.55%). 
 
(E)-4-Nitrocinnamyl (toluene-4-sulfonyl)acetate (1f): p-Nitrocinnamyl alcohol (448 
mg, 2.50 mmol), p-toluenesulfonylacetic acid (536 mg, 2.50 mmol) and N,N’-
diisopropylcarbodiimide (0.39 ml, 2.50 mmol, 1.0 equiv) were employed in general 
procedure 1. Chromatography (40:60 EtOAc:petrol) gave 1f (884 mg, 94%) as a pale 
yellow solid; m. pt. 90-91 °C; Rf 0.44 (50:50 EtOAc:petrol); max (film) 3006, 2945, 
1743, 1597, 1516, 1450, 1344, 1327, 1275, 1151, 1111, 1086, 972, 862, 816, 741, 644 
cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 2.41 (s, 3H, Ts-CH3), 4.19 (s, 2H, -SO2-
CH2-), 4.81 (d, 
3
JH,H = 5.5 Hz, 2H, -O-CH2-), 6.35 (dt, 
3
JH,H = 16.0, 5.5 Hz, 1H, Ar-
CH=CH-), 6.71 (d, 
3
JH,H = 16.0 Hz, 1H, Ar-CH=), 7.34 (d, 
3
JH,H = 8.0 Hz, 2H, m-SO2-
Ar), 7.51 (d, 
3
JH,H = 8.5 Hz, 2H, m-NO2-Ar), 7.82 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar) 8.19 
(d, 
3
JH,H = 8.5 Hz, 2H, o-NO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.7 (Ts-CH3), 
61.0 (Ts-CH2-), 65.8 (-O-CH2-), [124.1, 126.7, 127.3, 128.6, 129.9 and 132.0] (3°), 
[135.7, 142.3, 145.6 and 147.3] (4°), 162.2 (C=O); m/z (CI) 393 [M+NH4]
+
, 321, 222, 
205, 188, 134, 52 (Found: [M+NH4]
+
, 393.1122 C18H17NO6S requires [M+NH4]
+
, 
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393.1120) (Found: C, 57.76; H, 4.56; N, 3.85. C18H17NO6S requires C, 57.59; H, 4.56; N, 
3.73%) 
 
 
(E)-5-(Trimethylsilyl)pent-2-en-4-ynyl (toluene-4-sulfonyl)acetate (1g):  5-
(Trimethylsilyl)pent-2-en-4-yn-1-ol (2.31 g, 15.0 mmol), p-toluenesulfonylacetic acid 
(3.21 g, 15.0 mmol) and N,N’-diisopropylcarbodiimide (2.35 ml, 15.0 mmol) were 
employed in general procedure 1. Chromatography (30:70 EtOAc:petrol) gave 1g (3.40 g, 
65%) as a pale yellow solid. A small portion was recrystallised from EtOAc/hexanes to 
give a white crystalline solid; m. pt. 78ºC; Rf 0.57 (50:50 EtOAc:petrol); max (film) 
3003, 2958, 2900, 2179, 2135, 1745, 1597, 1402, 1329, 1269, 1252, 1151, 1086, 955, 
845, 760, 727, 644 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 0.12 (s, 9H, -Si(CH3)3), 
2.36 (s, 3H, Ts-CH3), 4.07 (s, 2H, -SO2-CH2-), 4.47 (d, 
3
JH,H = 6.0 Hz, 2H, -O-CH2-), 
5.53 (d, 
3
JH,H = 16.0 Hz, 1H, -O-CH2-CH=CH-), 5.91 (dt, 
3
JH,H = 16.0, 6.0 Hz, 1H, -O-
CH2-CH=), 7.28 (d, 
3
JH,H = 8.0 Hz, d, m-SO2Ar), 7.71 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = -0.2 (-Si(CH3)3), 21.7 (Ts-CH3), 60.8 (-SO2-
CH2-), 65.1 (-O-CH2-), [96.6 and 102.3] (4°), [114.0, 128.5 and 129.9] (3°), 135.6 (4°), 
136.0 (3°), 145.4 (4°), 162.0 (C=O); m/z (CI) 368 [M+NH4]
+
, 339, 214, 188, 154, 90 
(Found: [M+NH4]
+
, 368.1344. C17H22O4SSi requires [M+NH4]
+
, 368.1352) (Found: C, 
57.94; H, 6.25. C17H22O4SSi requires C, 58.25; H, 6.33%). 
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Allyl Carbonates 7 
 
 
Carbonate 
(yield) 
Structure
 
 
7a (76%) 
 
7b (86%) 
 
7c (91%) 
 
7d (75%) 
 
 
 
General procedure (2) for the synthesis of (p-nitrophenyl) allyl carbonates  (7a-e) 
To desired 3-substituted allyl alcohol (1.0 equiv) and p-nitrophenyl chloroformate (1.1 
equiv) CH2Cl2 (0.2 M). under N2 at -10 °C was added dropwise triethylamine (2.0 equiv). 
The reaction mixture was stirred at -10 °C for 30 min, then at rt for 16 h. The reaction 
mixture was partitioned between EtOAc (15 ml mmol
-1
) and saturated NH4Cl(aq) (7.5 ml 
mmol
-1
). The organic phase was washed with saturated NH4Cl(aq) (2 × 7.5 ml mmol
-1
), 
dried (Na2SO4) and concentrated under reduced pressure. Chromatography (EtOAc-
petrol) or recrystallisation afforded the p-nitrophenyl allyl carbonates in good yield. 
(2E,4E)-Hexa-2,4-dienyl 4-nitrophenyl carbonate (7a): p-Nitrophenyl chloroformate 
(4.44 g, 22 mmol), (2E,4E)-hexa-2,4-dien-1-yl alcohol (1.96 g, 20 mmol) and 
triethylamine (5.58 ml, 40 mmol) were employed in general procedure 2. 
Chromatography (15:85 EtOAc:petrol) gave 7a (3.99 g, 76%) as a white solid; m. pt. 92 
°C; Rf 0.48 (20:80 EtOAc:petrol); max (film) 3116, 3086, 3005, 2943, 1749, 1660, 1531, 
O
OO
O2N
O
OO
O2N
Ph
O
OO
O2N
O
OO
O2N
TMS
 24 
1493, 1350, 1300, 1273, 1221, 1107, 997, 980, 939, 858, 777, 723, cm
-1
; 
1
H NMR (300 
MHz, CDCl3, 25°C): δ = 1.81 (d, 
3
JH,H = 6.5 Hz, 3H, =CH-CH3), 4.79 (d, 
3
JH,H = 7.0 Hz, 
2H, -O-CH2-), 5.66-5.92 (m, 2H, -O-CH2-CH= and =CH-CH3), 6.07-6.15 (m, 1H, -O-
CH2-CH=CH-CH=), 6.38 (dd, 
3
JH,H = 15.0, 10.5 Hz, 1H, -O-CH2-CH=CH-), 7.40 (d, 
3
JH,H = 9.0 Hz, 2H, m-NO2-Ar), 8.31 (d, 
3
JH,H = 9.0 Hz, 2H, o-NO2-Ar); 
13
C NMR (75 
MHz, CDCl3, 25°C): δ = 18.2 (-CH3), 69.9 (-O-CH2-), [121.6, 121.8, 125.3, 130.1, 132.8 
and 137.0] (3°), [145.4, 152.4 and 155.6] (4°); m/z (CI) 281 [M+NH4]
+
, 252, 234, 217, 
110 (Found: [M+NH4]
+
, 281.1137. C13H13NO5 requires [M+NH4]
+
, 281.1137) (Found: C, 
59.10; H, 4.79; N, 5.33. C13H13NO5 requires C, 59.31; H, 4.94; N, 5.32%). 
 
Cinnamyl p-nitrophenyl carbonate (7b): p-Nitrophenyl chloroformate (8.87 g, 44 
mmol), cinnamyl alcohol (5.37 g, 40 mmol), and triethylamine (11.15 ml, 80 mmol) were 
employed in general procedure 2. Recrystallisation from 20% TBME-petrol gave 7b 
(10.27 g, 86%) as a white crystalline solid; m. pt. 78 °C (lit.
[22]
 77 °C); Rf 0.28 (20:80 
EtOAc:petrol); max (film) 3116, 3084, 3060, 3028, 2954, 1763, 1616, 1593, 1523, 1493, 
1448, 1348, 1255, 1211, 1109, 968, 858, 746, 692 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 
25°C): δ = 4.96 (d, 3JH,H = 6.5 Hz, 2H, -CH2-O-), 6.38 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ph-
CH=CH-), 6.80 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 7.28-7.47 (m, 7H, other Ar-H), 8.31 
(d, 
3
JH,H = 9.0 Hz, 2H, o-NO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 155.6 (4° 
-NO2Ar), 152.4 (-OCO2-), 145.4 (4° -NO2Ar), 136.3, 135.7 (4° Ph), 128.8, 128.6, 126.8, 
125.4, 121.9, 121.2, 69.9 (-CH2-O-); m/z (CI) 317 [M+NH4]
+
, 273, 252, 226, 157, 151, 
134 [C9H10O]
+
, 117 [C9H9]
+
 (Found: [M+NH4]
+
, 317.1147. C16H13NO5 requires 
[M+NH4]
+
, 317.1137) (Found: C, 64.34; H, 4.27; N, 4.58. C16H13NO5 requires C, 64.21; 
H, 4.38; N, 4.68%). 
 
Allyl p-nitrophenyl carbonate (7c): p-Nitrophenyl chloroformate (4.44 g, 22 mmol), 
allyl alcohol (1.36 ml, 20 mmol) and triethylamine (11.1 ml, 80 mmol) were employed in 
general procedure 2. Chromatography (15:85 EtOAc-petrol) afforded 7c (4.04 g, 91%) as 
an off-white solid; m. pt. 49 °C; Rf 0.48 (20:80 EtOAc:petrol); max (film) 3120, 3086, 
2954, 2854, 1753, 1614, 1595, 1518, 1489, 1361, 1300, 1265, 1225, 1163, 1105, 1051, 
993, 939, 856, 775, 727, 677 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 4.80 (d, 
3
JH,H 
= 6.0 Hz, 2H, -O-CH2-), 5.37-5.51 (m, 2H, -CH=CH2), 5.96-6.09 (m, 1H, -CH=CH2), 
7.41 (d, 
3
JH,H = 9.0 Hz, 2H, m-NO2-Ar), 8.30 (d, 
3
JH,H = 9.0 Hz, 2H, o-NO2-Ar), in 
agreement with previously reported values
[23]
; 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 
 25 
69.8 (-O-CH2-), 120.2 (=CH2), [121.8, 125.3 and 130.6] (3°), [145.4, 152.3 and 155.5] 
(4°); m/z (CI) 241 [M+NH4]
+
, 211, 194, 157, 148, 110, 108 (Found: [M+NH4]
+
, 
241.0826. C10H9NO5 requires [M+NH4]
+
, 241.0824) (Found: C, 53.73; H, 3.93; N, 6.19. 
C10H9NO5 requires C, 53.82; H, 4.06; N, 6.28%). 
 
p-Nitrophenyl (E)-5-trimethylsilanylpent-2-en-4-ynyl carbonate (7d): p-Nitrophenyl 
chloroformate (2.22 g, 11 mmol), (E)-5-(trimethylsilyl)pent-2-en-4-yn-1-ol (1.54 g, 10 
mmol) and triethylamine (2.79 ml, 20 mmol) were employed in general procedure 2. 
Chromatography (15:85 EtOAc:petrol) gave 7d (2.40 g, 75%) as a colourless oil; Rf 0.52 
(20:80 EtOAc:petrol); max (film) 3118, 3087, 2960, 2177, 2137, 1768, 1616, 1595, 1527, 
1493, 1350, 1252, 1215, 1165, 1084, 953, 920, 847, 760, cm
-1
; 
1
H NMR (300 MHz, 
CDCl3, 25°C): δ = 0.21 (s, 9H, -Si(CH3)3), 4.80 (d, 
3
JH,H = 6.5 Hz, 2H, -O-CH2-), 5.90 (d, 
3
JH,H = 16.0 Hz, 1H, -O-CH2-CH=CH-), 6.28 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, -O-CH2-
CH=), 7.39 (d, 
3
JH,H = 9.0 Hz, 2H, m-NO2-Ar), 8.29 (d, 
3
JH,H = 9.0 Hz, 2H, o-NO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = -0.2 (-Si(CH3)3), 68.4 (-O-CH2-), 97.6 (-C≡C-
Si(CH3)3), 101.8 (-C≡C-Si(CH3)3), 115.4, 121.8, 125.4, 135.3, 145.5, 152.2, 155.4; m/z 
(CI) 337 [M+NH4]
+
, 307, 229, 171, 154, 137, 90, 76, 52 (Found: [M+NH4]
+
, 337.1219. 
C15H17NO5Si requires [M+NH4]
+
, 337.1220) (Found: C, 56.69; H, 5.27; N, 4.36. 
C15H17NO5Si requires C, 56.41; H, 5.36; N, 4.39%). 
 
 
Preparation of Allyl alcohols. 
 
 Allyl alcohol was purchased from Aldrich Chemical Co. Inc. and distilled prior to 
use. 
 
 Cinnamyl alcohol and p-nitrocinnamyl alcohol were purchased from Lancaster 
Synthesis Ltd. 
 
 Pent-2-enyl alcohol and (2E,4E)-hexa-2,4-dien-1-yl alcohol were purchased from 
Aldrich Chemical Co. Inc. 
 
 p-Methoxycinnamyl alcohol was prepared in accordance with previously reported 
procedures, in two steps from p-anisaldehyde, purchased from Aldrich Chemical 
Co. Inc.  
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Step 1: Ethyl p-methoxycinnamate: To a suspension of sodium hydride (720 mg, 30 
mmol, 1.0 equiv) in THF (60 ml) at 0 °C was added triethylphosphonoacetate (7.06 g, 
31.5 mmol, 1.05 equiv, solution in THF, 30 ml) dropwise via a cannula. The reaction 
mixture was stirred for 30 min at 0 °C, then p-anisaldehyde 61 (3.64 ml, 30 mmol, 1.0 
equiv, solution in THF, 30 ml) was introduced dropwise via a cannula with vigorous 
stirring. The reaction mixture was allowed to warm to rt and stirred for 41 h before 
dilution with EtOAc (100 ml). The organic phase was washed with saturated NH4Cl(aq) (2 
× 75ml), dried (Na2SO4), concentrated under reduced pressure and purified by 
chromatography (5:95 EtOAc:petrol) to give ethyl p-methoxycinnamate (4.78 g, 77%) as 
a white crystalline solid; Rf 0.35 (20:80 EtOAc:petrol); 
1
H NMR (300 MHz, CDCl3, 
25°C): δ = 1.34 (t, 3JH,H = 7.0 Hz, 3H, -O-CH2-CH3), 3.84 (3H, s, Ar-O-CH3), 4.26 (q, 
3
JH,H = 7.0 Hz, 2H, -O-CH2-CH3), 6.32 (d, 
3
JH,H = 16.0 Hz, 1H, Ar-CH=CH-), 6.91 (d, 
3
JH,H = 8.5 Hz, 2H, o-MeO-Ar), 7.48 (d, 
3
JH,H = 8.5 Hz, 2H, m-MeO-Ar), 7.65 (d, 
3
JH,H = 
16.0 Hz, 1H, Ar-CH=); data in agreement with those previously reported.
[24]
 
Step 2: p-Methoxycinnamyl alcohol: To a solution of ethyl p-methoxycinnamate (4.78 
g, 23.2 mmol, 1.0 equiv) in CH2Cl2 (100 ml) at -78 °C was added dropwise over 5min di-
isobutyl aluminium hydride (1.0M in CH2Cl2, 83.5 ml, 83.5 mmol, 3.6 equiv). The 
reaction mixture was stirred at -78 °C for 30 min then allowed to warm to rt over 45min. 
Dropwise addition of EtOAc (10 ml) to the reaction mixture was followed by the reaction 
mixture being slowly poured into a solution of 100ml saturated aqueous sodium 
potassium tartrate solution and 100 ml H2O with vigorous stirring. The reaction mixture 
was stirred at rt for 14 h then the organic phase was washed with saturated NaCl(aq) (2 × 
100ml), dried (Na2SO4), concentrated under reduced pressure and purified by 
chromatography (20:80 to 50:50 EtOAc:petrol) to give p-methoxycinnamyl alcohol (3.27 
g, 86%) as a white crystalline solid; Rf 0.09 (20:80 EtOAc:petrol); 
1
H NMR (300 MHz, 
CDCl3, 25°C): δ = 1.63 (br s, 1H, -OH), 3.83 (s, 3H, Ar-O-CH3), 4.31 (d, 
3
JH,H = 6.0 Hz, 
2H, -CH2-O-), 6.21-6.30 (1H, m, Ar-CH=CH-), 6.57 (1H, d, 
3
JH,H = 16.0 Hz, Ar-CH=), 
6.88 (d, 
3
JH,H = 8.0 Hz, 2H, o-MeO-Ar), 7.34 (d, 
3
JH,H = 8.0 Hz, 2H, m-MeO-Ar); data in 
agreement with those previously reported.
[25]
 
 
 (E)-5-(trimethylsilyl)pent-2-en-4-yn-1-ol was prepared in one step in accordance 
with a previously reported procedure from pent-2-en-4-yn-1-ol, purchased as an 
unspecified mixture of (E) and (Z) isomers from Lancaster Synthesis Ltd. 
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(E)-5-Trimethylsilyl-pent-2-en-4-yn-1-ol: To a solution of pent-2-en-4-yn-1-ol (mixture 
of E/Z isomers, 4.11 g, 50 mmol, 1.0 equiv) in THF (85 ml) at -78 °C was added n-
butyllithium (2.48M; in THF, 40.3 ml, 100 mmol,  2.0 equiv). A green precipitate 
formed; to this was added chlorotrimethylsilane (10.86 g, 100 mmol, 2.0 equiv). The 
reaction mixture was stirred at -78 °C for 30 min then allowed to warm to rt over 30 min. 
The reaction mixture was poured over 2M HCl(aq) (200 ml), then extracted with Et2O (100 
ml). The organic phase was washed with 2M HCl(aq) (200 ml), dried (Na2SO4) and 
concentrated under reduced pressure. Chromatography (15:85 EtOAc:petrol) yielded (E)-
5-trimethylsilanyl-pent-2-en-4-yn-1-ol (983 mg, 66%) as a colourless liquid; 
1
H NMR 
(300 MHz, CDCl3, 25°C): δ = 0.20 (s, 9H, -Si(CH3)3), 1.80 (br s, 1H, -OH), 4.20 (d, 
3
JH,H 
= 5.0 Hz, 2H, HO-CH2-), 5.78 (d, 
3
JH,H = 16.0 Hz, 1H, HO-CH2CH=CH-), 6.31 (dt, 
3
JH,H 
= 16.0, 5.0 Hz, 1H, HO-CH2-CH=); data in agreement with those previously reported.
[26]
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Synthesis of Tosylmalonates 5 
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General procedure (3) for the synthesis of 2-(Toluene-4-sulfonyl)malonic acid 
bis(allyl) esters (5a-g) 
To NaH (2.0 equiv) under N2 at 0°C was added via cannula a solution of desired tosyl 
monoester 1 (1.0 equiv) in DMF (5 ml mol
-1
, dry), resulting in effervescence. The 
reaction mixture was stirred for 15 min, then a solution of desired p-nitrocinnamyl allyl 
carbonate 7 (1.0 equiv) in DMF (5 ml mol
-1
, dry) was introduced via cannula. The yellow 
reaction mixture was stirred at 0°C for 15 min, then at rt for 16 h. The reaction mixture 
was then diluted with EtOAc (10 ml mmol
-1
) and washed with H2O (2 × 10 ml mmol
-1
). 
The organic phase was dried over Na2SO4, concentrated under reduced pressure and 
purified by chromatography (EtOAc-PhMe or Et2O-CH2Cl2, with NEt3 or AcOH additive 
as necessary) to give the desired 2-(toluene-4-sulfonyl)malonic acid bis(allyl) ester 5. 
 
 
(±)-((2E,4E)-Hexa-2,4-dienyl)(4-methoxycinnamyl)-2-(toluene-4-sulfonyl)malonate 
(5a): sodium hydride (254 mg, 6.34 mmol), (E)-4-methoxycinnamyl (toluene-4-
sulfonyl)acetate 1a (1.141 g, 3.17 mmol) and p-nitrophenyl (2E,4E)-hexa-2,4-dien-1-yl 
carbonate 7a (834 mg, 3.17 mmol) were employed in general procedure 3, with the 
following additions: The ethyl acetate solution of the crude product was concentrated 
under reduced pressure without heating. Chromatography (70:927:3 EtOAc:PhMe:NEt3) 
gave an inseparable mixture of the desired product and unreacted 1a. This mixture was 
dissolved in DMF (15 ml, dry), to which was added at 0 °C DBU (1.59 ml, 15.9 mmol, 
5.0 equiv) and sodium iodoacetate (3.30 g, 15.9 mmol, 5.0 equiv). The reaction mixture 
was allowed to warm to rt with stirring over 2 h, then diluted with CH2Cl2 (40 ml). The 
resultant white suspension was washed with H2O (40 ml), then the aqueous layer was 
backwashed with a small portion of CH2Cl2. The combined organic layers were dried 
over Na2SO4, concentrated under reduced pressure without heating and purified by 
chromatography (200:800:3 EtOAc:hexane:NEt3) to give pure 5a (249 mg, 16%) as a 
colourless oil; Rf 0.18 (20:80 EtOAc:hexane); max (film) 2924, 2853, 1738, 1606, 1612, 
1444, 1378, 1333, 1247, 1175, 1148, 1082, 1031, 991, 968, 841, 814, 706 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3, 25°C): δ = 1.75 (d, 
3
JH,H = 6.5 Hz, 3H, =CH-CH3), 2.38 (s, 3H, Ts-
CH3), 3.81 (s, 3H, -OCH3), 4.65 (d, 
3
JH,H = 7.0 Hz, 2H, -CH2-O-), 4.77 (d, 
3
JH,H = 5.5 Hz, 
2H, -CH2-O-), 4.98 (1H, s, -OCO-CH(Ts)-COO-), 5.50 (dt, 
3
JH,H = 14.5, 7.0 Hz, 1H=CH-
CH3), 5.70-5.78 (m, 1H, -O-CH2-CH=CH-CH=), 5.94-6.01 (1H, m, -O-CH2-CH=CH-
CH=), 6.03 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, p-MeO-C6H4-CH=CH-), 6.21 (dd, 
3
JH,H = 15.0, 
10.5 Hz, 1H, -O-CH2-CH=CH-CH=), 6.58 (d, 
3
JH,H = 16.0 Hz, 1H, MeO-C6H4-CH=), 
6.86 (d, 
3
JH,H = 9.0 Hz, 2H, o-MeO-Ar), 7.25-7.31 (m, 4H, other Ar-H), 7.83 (d, 
3
JH,H = 
 30 
8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (100 MHz, CDCl3, 25°C): δ = 18.1 (=CH-CH3), 21.7 
(Ts-CH3), 55.3 (-OCH3), [67.4 and 67.7] (2 × -CH2-O-), 74.7 (-OCO-CH(Ts)-COO-), 
[114.1, 119.0, 121.8 and 128.0] (3°), 128.6 (4°), [129.4, 2 × 130.2 and 132.2 ] (3°), 134.2 
(4°), [135.5 and 136.3] (3°), 145.9 (4° SO2-Ar), 159.8 (4° MeO-Ar), 160.8 (2 × C=O); 
m/z (-ve ESI) 483 [M-H]
-
, 457 (Found: 483.1467. C26H28O7S requires [M-H]
-
 483.1483) 
(Found: C, 64.37; H, 6.04. C26H28O7S requires C, 64.47; H, 5.83%). 
 
(±)-(Cinnamyl)(4-methoxycinnamyl)-2-(toluene-4-sulfonyl)malonate (5b): sodium 
hydride (480 mg, 20 mmol),  (E)-4-methoxycinnamyl (toluene-4-sulfonyl)acetate 1a 
(3.60 g, 10 mmol) and cinnamyl p-nitrophenyl carbonate 7b (2.99 g, 10 mmol) were 
employed in general procedure 3. Chromatography (4:96 EtOAc:PhMe) gave 5b (2.03 g, 
39%) as a pale yellow oil; Rf 0.62 (50:50 EtOAc:petrol); max (film) 3028, 2954, 2839, 
1741, 1606, 1512, 1448, 1377, 1334, 1252, 1176, 1149, 1082, 1032, 970, 843, 814, 746, 
706, 694, 671 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 2.35 (s, 3H, Ts-CH3), 3.81 
(3H, s, Ar-O-CH3), 4.79-4.84 (m, 4H, -O-CH2-), 5.04 (s, 1H, -OCO-CH(Ts)-COO-), 
[6.04 and 6.17] (each dt, 
3
JH,H = 16.0, 6.5 Hz, each 1H, Ph-CH=CH- and MeO-Ar-
CH=CH-), [6.59 and 6.64] (each d, 
3
JH,H = 16.0 Hz, each 1H, Ph-CH= and MeO-Ar-
CH=-), 6.84 (dt, 
3
JH,H = 9.0 Hz, 
4
JH,H = 2.5 Hz, 2H, o-MeO-Ar), 7.21-7.36 (m, 9H, other 
Ar-H), 7.85 (dt, 
3
JH,H = 8.5 Hz, 
4
JH,H = 2.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, 
CDCl3, 25°C): δ = 21.7 (Ts-CH3), 55.3 (Ar-O-CH3), [67.5 and 67.9] (2 -O-CH2-), 74.6 
(-OCO-CH(Ts)-COO-), 114.1, 118.9, 121.3, 126.8, 128.1, 128.4, 128.6, 128.7, 129.5 (4° 
-MeO-Ar), 130.3, 134.1, 2 × 135.6, 135.8, 146.0 (4° -SO2-Ar), 159.9 (4° -MeO-Ar), 
160.8 (2 C=O); m/z (FAB) 521 [MH]+, 520, 430, 338, 147 [C10H11O]
+
, 117 [C9H9]
+
, 109 
(Found: [M]
+
, 520.1570. C29H28O7S requires [M]
+
, 520.1556) (Found: C, 66.85; H, 5.60. 
C29H28O7S requires C, 66.91; H, 5.42%).  
 
(±)-(Cinnamyl)((2E,4E)-hexa-2,4-dienyl)-2-(toluene-4-sulfonyl)malonate (5c): 
Sodium hydride (480 mg, 20 mmol), (2E,4E)-Hexa-2,4-dienyl (toluene-4-
sulfonyl)acetate 1b (2.94 g, 10 mmol) and cinnamyl p-nitrophenyl carbonate 7b (2.99 g, 
10 mmol, 1.0 equiv) were employed in general procedure 3. Chromatography (10:987:3 
Et2O:CH2Cl2:AcOH, then 4:96 EtOAc:PhMe) gave 5c (1.36 g, 30%) as a yellow oil; Rf 
0.18 (20% EtOAc-petrol); max (film) 3026, 2937, 1741, 1660, 1597, 1495, 1448, 1379, 
1336, 1271, 1151, 1082, 991, 970, 814, 746, 706, 692, 673 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3, 25°C): δ = 1.77 (d, 
3
JH,H = 6.5 Hz, 3H, CH3-CH=), 2.40 (s, 3H, Ts-CH3), [4.68 
 31 
and 4.84] (each d, 
3
JH,H = 6.5 Hz, each 2H, 2 × -CH2-O-), 5.03 (s, 1H, -CH(Ts)-COO-), 
5.49-5.58 (m, 1H, CH3-CH=), 5.73-5.83 (m, 1H, CH3-CH=CH-CH=CH-), 5.96-6.05 (m, 
1H, CH3-CH=CH-), 6.14-6.29 (m, 2H, Ph-CH=CH- and CH3-CH=CH-CH=), 6.66 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 7.28-7.39 (m, 7H, other Ar-H), 7.86 (d, 
3
JH,H = 8.0 Hz, 
2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 18.2 (=CH-CH3), 21.8 (Ts-CH3), 
[67.4 and 67.5] (2 × -O-CH2-), 74.6 (-CH(Ts)-COO-), 121.2, 121.8, 126.8, 128.4, 128.7, 
129.5, 130.2, 130.3, 132.3, 134.1 (4° Ph), 135.6, 135.8, 136.4, (4° -SO2Ar), 146.0 (4° 
-SO2Ar), 2 × 160.8 (2 × C=O); m/z (CI) 472 [M+NH4]
+
, 436, 348, 312, 297, 231, 188, 
134 [C9H10O]
+
, 117 [C9H9]
+
, 98 [C6H10O]
+
, 81 [C6H9]
+
 (Found: 472.1777. [M+NH4]
+
, 
C25H26O6S requires [M+NH4]
+
, 472.1794).  
 
 
(±)-(Cinnamyl)((2E)-pent-2-enyl)-2-(toluene-4-sulfonyl)malonate (5d): Sodium 
hydride (48 mg, 2.0 mmol), (E)-pent-2-enyl (toluene-4-sulfonyl)acetate 1d (282 mg, 1.0 
mmol) and cinnamyl p-nitrophenyl carbonate 7b (299 mg, 1.0 mmol, 1.0 equiv) were 
employed in general procedure 3. Chromatography (10:987:3 Et2O:CH2Cl2:AcOH) gave 
5d (250 mg, 56%) as a yellow oil; Rf 0.62 (5:95 Et2O:CH2Cl2); max (film) 2962, 2933, 
1741, 1597, 1495, 1450, 1377, 1336, 1261, 1149, 1082, 968, 814, 744, 706, 694, 669 
cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 0.99 (t, 
3
JH,H = 7.0 Hz, 3H, -CH2-CH3), 
2.01-2.10 (m, 2H, -CH2-CH3), 2.40 (s, 3H, Ts-CH3), 4.63 (d, 
3
JH,H = 6.5 Hz, 2H, -CH2-
CH=CH-CH2-CH3), 4.84 (d, 
3
JH,H = 6.5 Hz, 2H, Ph-CH=CH-CH2-), 5.04 (s, 1H, 
-CH(Ts)-), 5.50 (dt, 
3
JH,H = 15.5, 6.0 Hz, 1H, -O-CH2-CH=CH-CH2-), 5.84 (dt, 
3
JH,H = 
15.5, 6.0 Hz, 1H, -O-CH2-CH=CH-CH2-), 6.19 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ph-
CH=CH-), 6.57 (1H, d, 
3
JH,H = 16.0 Hz, Ph-CH=), 7.19-7.29 (m, 7H, other Ar-H), 7.78 
(d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 13.0 (-CH2-
CH3), 21.8 (Ts-CH3), 25.3 (-CH2-CH3), 67.5 (Ph-CH=CH-CH2-), 67.8 (-O-CH2-CH=CH-
CH2-), 74.6 (-CH(Ts)-), [121.2 and 121.3] (Ph-CH=CH- and -O-CH2-CH=CH-CH2), 
[126.8, 128.4 and 128.7] (3° Ph), 129.5 (3° SO2-Ar), 130.3 (3° SO2-Ar), 134.1 (4° SO2-
Ar), 135.6 (Ph-CH=), 135.8 (i-Ph), 139.7 (-O-CH2-CH=CH-CH2-), 146.0 (4° SO2-Ar), 
[160.8 and 160.9] (2 × C=O); m/z (CI) 460 [M+NH4]
+
, 338, 300, 188, 174, 146, 134 
[C9H10O]
+
, 117 [C9H9]
+
 (Found: [M+NH4]
+
, 460.1784 C24H26O6S requires [M+NH4]
+
, 
460.1794) (Found: C, 65.31; H, 6.11. C24H26O6S requires C, 65.14; H, 5.92%). 
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(±)-(Allyl)(cinnamyl)-2-(toluene-4-sulfonyl)malonate (5e): Sodium hydride (480 mg, 
20 mmol), allyl (toluene-4-sulfonyl)acetate 1e (2.54 g, 10 mmol) and cinnamyl p-
nitrophenyl carbonate 7b (2.99 g, 10.0 mmol) were employed in general procedure 3. 
Chromatography (10:987:3 Et2O:CH2Cl2:AcOH, then 3:97 EtOAc:PhMe) gave 5e (1.89 
g, 46%) as a colourless oil; Rf 0.34 (50:50 EtOAc:petrol); max (film) 3058, 3027, 2946, 
1743, 1596, 1494, 1449, 1336, 1276, 1151, 1084, 970, 939, 815, 747, 705, 694, 673 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 2.40 (s, 3H, Ts-CH3), 4.69 (d, 
3
JH,H = 5.0 Hz, 2H, 
-CH2-CH=CH2), 4.84 (d, 
3
JH,H = 6.5 Hz, 2H, Ph-CH=CH-CH2-), 5.05 (s, 1H, -CH(Ts)-), 
5.24-5.38 (m, 2H, -CH=CH2), 5.80-5.91 (m, 1H, -CH=CH2), 6.19 (dt, 
3
JH,H = 16.0, 6.5 
Hz, 1H, Ph-CH=CH-), 6.66 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 7.28-7.40 (m, 7H, other 
Ar-H), 7.87 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 
21.8 (Ts-CH3), [67.4 and 67.5] (2× -O-CH2-), 74.6 (-SO2-CH<), 119.7, 121.3, 126.8, 
128.5, 128.7, 129.6, 130.3, 130.5, 130.7, 134.1, 135.8, 146.1, [160.7 and 160.8] (2 × 
C=O); m/z (CI) 432 [M+NH4]
+
, 388, 356, 272, 202, 174, 134 [C9H10O]
+
, 117 [C9H9]
+
 
(Found: [M+NH4]
+
, 432.1481. C22H22O6S requires [M+NH4]
+
, 432.1481) (Found: C, 
63.78; H, 5.40. C22H22O6S requires C, 63.75; H, 5.35%). 
 
 
(±)-(Cinnamyl)(5-trimethylsilanylpent-2-en-4-ynyl)-2-(toluene-4-sulfonyl)malonate 
(5f): Sodium hydride (48 mg, 2.00 mmol), (E)-5-(trimethylsilyl)pent-2-en-4-ynyl 
(toluene-4-sulfonyl)acetate 1g (351 mg, 1.00 mmol) and cinnamyl p-nitrophenyl 
carbonate 7b (299 mg, 1.00 mmol) were employed in general procedure 3. 
Chromatography (10:987:3 Et2O:CH2Cl2:AcOH) gave 5f (143 mg, 28%) as a yellow oil; 
Rf 0.71 (5:95 Et2O:CH2Cl2); max (film) 3028, 2958, 2179, 2135, 1745, 1597, 1495, 1448, 
1377, 1336, 1252, 1151, 1084, 968, 847, 816, 760, 706, 694, 669 cm
-1
; 
1
H NMR (400 
MHz, CDCl3, 25°C): δ = 0.22 (s, 9H, -Si(CH3)3), 2.41 (s, 3H, Ts-CH3), 4.67 (ddd, 
3
JH,H = 
14.0, 6.0 Hz, 
4
JH,H = 1.5 Hz, 1H, -CHH-CH=CH-C≡), 4.71 (ddd, 
3
JH,H = 14.0, 6.0 Hz, 
4
JH,H = 1.5 Hz, 1H, -CHH-CH=CH-C≡), 4.81 (ddd, 
3
JH,H = 12.5, 6.5 Hz, 
4
JH,H = 1.5 Hz, 
1H, -CHH-CH=CH-Ph), 4.85 (ddd, 
3
JH,H = 12.5, 6.5 Hz, 
4
JH,H = 1.5 Hz, 1H, -CHH-
CH=CH-Ph), 5.04 (s, 1H, -CH(Ts)-), 5.73 (dt, 
3
JH,H = 16.0 Hz, 
4
JH,H = 1.5 Hz, 1H, 
-CH=CH-C≡), 6.10 (dt, 3JH,H = 16.0, 6.0 Hz, 1H, -CH=CH-C≡), 6.18 (dt, 
3
JH,H = 16.0, 6.5 
Hz, 1H, Ph-CH=CH-), 6.65 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 7.26-7.40 (m, 7H, other 
Ar-H), 7.84 (dt, 
3
JH,H = 8.5 Hz, 
4
JH,H = 2.0 Hz, 2H, o-SO2-Ar); 
13
C NMR (75 MHz, 
CDCl3, 25°C): δ = -0.2 (-Si(CH3)3), 21.8 (Ts-CH3), 65.9 (-CH2-CH=CH-C≡), 67.5 (-CH2-
CH=CH-Ph), 74.5 (-CH(Ts)-), 97.2 (-C≡C-Si(CH3)3), 102.0 (-C≡C-Si(CH3)3), 114.8 
 33 
(-CH=CH-C≡), 121.2 (Ph-CH=CH-), [126.8, 128.5 and 128.7] (3° Ph), 129.6 (m-SO2-
Ar), 130.2 (o-SO2-Ar), 134.0 (4° SO2-Ar), 135.3 (-CH=CH-C≡), 135.8 (i-Ph), 135.8 (Ph-
CH=), 146.2 (4° SO2-Ar), [160.5 and 160.7] (2× C=O); m/z (-ve CI) 509 [M-H]
-
, 375, 
213, 169, 155, 138 (Found: C, 63.71; H, 6.16. C27H30O6SSi requires C, 63.50; H, 5.92%).  
 
 
(±)-1-Cinnamyl 3-(E)-3-(4-nitrophenyl)allyl 2-(toluene-4-
sulfonyl)malonate (5g) and (3S*,4R*)-Cinnamyl 4-(4-nitrobenzyl)-2-oxo-3-(toluene-
4-sulfonyl)tetrahydrofuran-3-carboxylate (11): Sodium hydride (50 mg, 2.09 mmol), 
(E)-4-nitrocinnamyl (toluene-4-sulfonyl)acetate 1f (783 mg, 2.09 mmol) and cinnamyl p-
nitrophenyl carbonate 7b (625 mg, 2.09 mmol) were employed in general procedure 3. 
Chromatography (10:990:3 Et2O:CH2Cl2
:
AcOH) gave 11 (383 mg, 34%) as a pale yellow 
solid and 5g (261 mg, 23%) as a yellow oil. 
5g: Rf 0.63 (5:95 Et2O:petrol); max (film) 3113, 3059, 3028, 1743, 1657, 1597, 1516, 
1495, 1448, 1377, 1342, 1149, 1082, 1016, 970, 912, 862, 816, 737, 706, 692, 671 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 2.38 (s, 3H, Ts-CH3), 4.82 (ddd, 
3
JH,H = 6.5, 2.5, 
1.5 Hz, 2H, Ph-CH=CH-CH2O-), 4.90 (d, 
3
JH,H = 6.0 Hz, 2H O2N-C6H4-CH=CH-
CH2O-), 5.10 (s, 1H, -CH(Ts)-), 6.15 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ph-CH=CH-), 6.36 
(dt, 
3
JH,H = 16.0, 6.0 Hz, 1H, O2N-C6H4-CH=CH-), 6.62 (dd, 
3
JH,H = 16.0 Hz, 
4
JH,H = 1.0 
Hz, 1H, Ph-CH=), 6.71 (d, 
3
JH,H = 16.0 Hz, 1H, O2N-C6H4-CH=), 7.26-7.34 (m, 7H, 
other Ar-H), 7.44 (dd, 
3
JH,H = 9.0 Hz, 
4
JH,H = 2.0 Hz, 2H, m-NO2Ar), 7.86 (dd, 
3
JH,H = 
8.5 Hz, 
4
JH,H = 2.0 Hz, 2H, o-SO2Ar), 8.12 (dd, 
3
JH,H = 9.0 Hz, 
4
JH,H = 2.0 Hz, 2H, o-
NO2Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.8 (Ts-CH3), 66.5 (O2N-C6H4-
CH=CH-CH2O-), 67.6 (Ph-CH=CH-CH2O-), 74.5 (-CH(Ts)-), 121.1 (Ph-CH=CH-), 
124.0 (3° NO2Ar), 126.2 (O2N-C6H4-CH=CH-), 126.7 (3° Ph), 127.3 (3° NO2Ar), [128.6, 
128.7] (3° Ph), [129.6, 130.2] (3° SO2Ar), 132.3 (O2N-C6H4-CH=), 134.1 (4° SO2Ar), 
135.7 (4° Ph), 135.9 (Ph-CH=), 142.2 (4° NO2Ar), 146.2 (4° SO2Ar), 147.4 (4° NO2-Ar), 
160.7 (2× C=O); m/z (FAB) 536 [M+H]
+
, 486, 391, 133, 117, 91, 77, 69, 57 (Found: C, 
63.09; H, 4.95; N, 2.65. C28H25NO8S requires C, 62.79; H, 4.71; N, 2.62%). 
11: mp 192 °C; Rf 0.74 (5% Et2O–CH2Cl2); max (film) 3107, 3078, 3059, 3028, 1793, 
1751, 1597, 1522, 1495, 1448, 1379, 1348, 1329, 1308, 1244, 1213, 1178, 1151, 1111, 
1084, 1059, 1038, 1018, 970, 910, 879, 854, 816, 735, 694, 665 cm
-1
; 
1
H NMR (500 
MHz, CDCl3, 25°C): δ = 2.36 (s, 3H, Ts-CH3), [2.59 (t, 
3
JH,H = 13.5 Hz, 1H), 3.56 (dd, 
3
JH,H = 13.5, 3.5 Hz, 1H)] (p-O2N-C6H4-CH2-), 3.88-3.95 (m, 1H, Ts-C-CH<), [4.03 (t, 
2
JH,H = 9.0 Hz, 1H), 4.31 (t, 
2
JH,H = 8.5 Hz, 1H)] (lactone -OCH2-), [4.75, 4.88] (ddd, 
2
JH,H = 12.5 Hz, 
3
JH,H = 6.5, 1.0 Hz, 2H, -CH=CH-CH2-), 6.15 (dt, 
3
JH,H = 16.0, 7.0 Hz, 
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1H, Ph-CH=CH-), 6.65 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 7.25-7.36 (m, 9H, m-NO2Ar, 
m-SO2Ar, 5× Ph-H), 8.02 (d, 
3
JH,H = 8.5 Hz, 2H, o-SO2Ar), 8.14 (d, 
3
JH,H = 8.5 Hz, 2H, 
o-NO2Ar),; 
13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.8 (Ts-CH3), 35.4 (p-O2N-C6H4-
CH2-), 42.7 (Ts-C-CH<), 67.8 (Ph-CH=CH-CH2O-), 70.0 (lactone -OCH2-), 78.1 (-OCO-
C(Ts)-COO-), 120.5 (3°), 124.3 (3°), 126.8 (3°), 128.8 (3°), 129.3 (3°), 129.6 (3°), 132.1 
(3°), 132.3 (4°), 135.4 (4°), 137.1 (3°), 144.2 (4°), 146.7 (4°), 147.3 (4°), [162.1, 166.9] 
(2× C=O); m/z (FAB) 536 [M+H]
+
, 248, 117 (Found: [M+H]
+
, 536.1364. C28H25NO8S 
requires [M+H]
+
, 536.1379) (Found: C, 62.59; H, 4.62; N, 2.59. C28H25NO8S requires C, 
62.79; H, 4.70; N, 2.62%).   
 
 
(±)-(Allyl)(5-(trimethylsilyl)pent-2-en-4-yn-1-yl)-2-(toluene-4-sulfonyl)malonate 
(5h): Sodium hydride (80 mg, 2.0 mmol), (E)-5-(trimethylsilyl)pent-2-en-4-ynyl 
(toluene-4-sulfonyl)acetate 1g (351 mg, 1.0 mmol) and allyl p-nitrophenyl carbonate 7c 
(223 mg, 1.0 mmol) were employed in general procedure 3, with the following additions: 
Rigorous care was taken to exclude moisture from the reaction mixture, otherwise 
desilylation of the product was observed. 1g was azeotropically dried from PhMe 
immediately prior to use. The EtOAc solution of the crude product was concentrated 
under reduced pressure without heating. Chromatography (40:957:3 EtOAc:PhMe:NEt3) 
gave 5h (73 mg, 17%) as a colourless oil; Rf 0.32 (5:95 EtOAc:PhMe); max (film) 2957, 
2137, 1742, 1597, 1449, 1337, 1250, 1151, 1082, 950, 843, 814, 760, 706 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3, 25°C): δ = 0.18 (s, 9H, -Si(CH3)3), 2.45 (3H, s, Ts-CH3), 4.66 (4H, d, 
3
JH,H = 6.5 Hz, 2 × -CH2-O-), 4.98 (s, 1H, -CH(Ts)-), 5.27 (d with fine struct., 
3
JH,H = 
10.5 Hz, 1H, HHC=CH- cis to H), 5.34 (d with fine struct., 
3
JH,H = 17.0 Hz, 1H, 
HHC=CH- trans to H), 5.70 (d, 
3
JH,H = 16.0 Hz, 1H, ≡C-CH=CH-), 5.80-5.89 (m, 1H, 
H2C=CH-), 6.07 (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, ≡C-CH=CH-), 7.35 (d, 
3
JH,H = 8.5 Hz, 2H, 
m-SO2-Ar), 7.83 (d, 
3
JH,H = 8.5 Hz, 2H, o-SO2-Ar); 
13
C NMR (100 MHz, CDCl3, 25°C): 
δ = -0.2 (-Si(CH3)3), 21.8 (Ts-CH3), [66.0 and 67.5] (2 × -CH2-O-), 74.5 (-CH(Ts)-), 97.1 
(Me3Si-C≡), 101.9 (Me3Si-C≡C-), 114.8 (3°), 119.0 (=CH2), [129.6, 130.2 and 130.4] 
(3°), 134.1 (4°), 135.2 (3°), 146.1 (4°), 160.5 (2 × C=O); m/z (-ve ESI) 433 [M-H]
-
, 361 
(Found: 433.1128. C21H26O6SSi requires [M-H]
-
 433.1147) (Found: C, 58.31; H, 6.17. 
C21H26O6SSi requires C, 58.04; H, 6.03%). 
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Synthesis of Monorearrangement products 6 
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6g (29%) 
 
6h (26%) 
 
 
General procedure (4) for the synthesis of tosylmalonate monorearrangement 
products 6: To desired 2-(toluene-4-sulfonyl)malonate bis(allyl) ester 5a-h (1.0 equiv) 
was added potassium acetate (oven-dried, 0.1 equiv). The reaction vessel was purged 
with N2, then CH2Cl2 (0.1M) was introduced via syringe. N,O-
bis(trimethylsilyl)acetamide (distilled, 1.0 or 2.0 equiv) was introduced via syringe. The 
reaction mixture was stirred at rt for 16h (unless otherwise specified), then concentrated 
under reduced pressure and purified by column chromatography (EtOAc-hexane or 
EtOAc-petrol, with basic additives as necessary) to give desired (toluene-4-
sulfonyl)monoester 6. 
 
 
(2E,4E)-Hexa-2,4-dienyl 3-(4-methoxyphenyl)-2-(toluene-4-sulfonyl)pent-4-enoate 
(6a): (±)-((2E,4E)-hexa-2,4-dienyl)(4-methoxycinnamyl)-2-(toluene-4-sulfonyl)malonate 
5a (64 mg, 0.132 mmol), potassium acetate (≈ 1 mg, 0.013 mmol) and N,O-
bis(trimethylsilyl)acetamide (33 µl, 0.132 mmol) were employed in general procedure 4, 
with the following additions: The reaction temperature was 0 °C, the reaction time was 2 
h; TLC indicated reaction completion. Chromatography (125:872:3 EtOAc:hexane:NEt3) 
gave 6a (55 mg, 95%) as a colourless oil; Rf 0.40 (20:80 EtOAc:hexane); max (film) 
2935 1736 1608 1597 1511 1443 1375 1323 1304 1247 1178 1141 1082 1032 990 923 
814 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ =1.76 (t, 
3
JH,H = 7.0 Hz, 3H, =CH-CH3, 2 
× diast.), 2.37 (s, 3H, Ts-CH3, min. diast.), 2.44 (s, 3H, Ts-CH3, maj. diast.), 3.73 (s, 3H, 
-OCH3, maj. diast.), 3.75 (s, 3H, -OCH3, min. diast.), 3.99-4.19 (m, 3H min. diast + 1H 
O
O
TMS Ts
O
O
Ts
Ph
O
O
Ts
Ph
NO2
NO2
+
3:1
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maj. diast., -O-CH2- min. diast & MeO-C6H4CH< 2 × diast.), 4.40 (d, 
3
JH,H = 11.5 Hz, 
1H, -OC(O)-C(Ts)H-, maj. diast.), 4.42 (d, 
3
JH,H = 10.5 Hz, 1H, -OC(O)-C(Ts)H-, min. 
diast.), 4.56-4.61 (m, 1H, -O-CHH-, maj, diast.), 4.96-5.04 (m, 1H, -O-CHH-, maj, 
diast.), 5.10 (d, 
3
JH,H = 17.0 Hz, 1H, HHC=CH-, trans to H, 2 × diast.), 5.14 (d, 
3
JH,H = 
10.5 Hz, 1H, HHC=CH-, cis to H, 2 × diast.), 5.29-6.25 (5H, m, 3° olefinic H), 6.69 (dt, 
3
JH,H = 9.0 Hz, 
4
JH,H = 2.0 Hz, 2H, m-MeO-Ar, min. diast.), 6.76 (dt, 
3
JH,H = 8.5 Hz, 
4
JH,H 
= 2.0 Hz, 2H, m-MeO-Ar, maj. diast.), 6.99 (dt, 
3
JH,H = 9.0 Hz, 
4
JH,H = 2.0 Hz, 2H, o-
MeO-Ar, min. diast.), 7.03 (dt, 
3
JH,H = 8.5 Hz, 
4
JH,H = 2.0 Hz, 2H, o-MeO-Ar, maj. 
diast.), 7.12 (d, 
3
JH,H = 8.5 Hz, 2H, m-SO2-Ar, min. diast.), 7.31 (d, 
3
JH,H = 8.0 Hz, 2H, m-
SO2-Ar, maj. diast.), 7.40 (d, 
3
JH,H = 8.5 Hz, 2H, o-SO2-Ar, min. diast.), 7.79 (d, 
3
JH,H = 
8.0 Hz, 2H, o-SO2-Ar, maj. diast.); 
13
C NMR (100 MHz, CDCl3, 25°C): δ = 18.1 (=CH-
CH3), 21.6 & 21.7 (Ts-CH3, 2 × diast.),  48.3 & 48.4 (MeO-C6H4-C(H)<, 2 × diast.), 55.1 
& 55.1 (-O-CH3, 2 × diast.), 66.2 & 66.7 (-O-CH2-, 2 × diast.), 75.0 & 75.5 (-OC(O)-
C(Ts)H-, 2 × diast.), 113.9 (3°), 114.0 (3°), 114.1 (3°), 117.6 & 117.4 (=CH2, 2 × diast.), 
122.2 (3°), 122.4 (3°), 127.9 (3°), 128.7 (3°), 129.0 (3°), 129.2 (3°), 129.3 (3°), 129.4 
(3°), 129.7 (3°), 129.7 (4°), 130.2 (3°), 131.1 (4°), 131.4 (3°), 131.8 (3°), 134.9 (4°), 
135.4 (3°), 135.9 (4°), 136.0 (3°), 136.7 (3°), 137.0 (3°), 144.4 &145.3 (4° SO2-Ar, 2 × 
diast.), 158.7 & 158.8 (4° MeO-Ar, 2 × diast.), 164.9 & 165.0 (C=O, 2 × diast.); m/z (-ve 
ESI) 439 [M-H]
-
, 351, 281, 226 (Found: 903.3212. C25H28O5S requires [2M+Na]
+
 
903.3206). 
 
(2R*,3S*)-Cinnamyl 3-(4-methoxyphenyl)-2-(toluene-4-sulfonyl)pent-4-enoate (6b): 
(±)-(cinnamyl)(4-methoxycinnamyl)-2-(toluene-4-sulfonyl)malonate 5b (288 mg, 0.553 
mmol), potassium acetate (≈ 5 mg, 0.06 mmol) and N,O-bis(trimethylsilyl)acetamide 
(135 µl, 0.55 mmol) were employed in general procedure 4, with the following additions: 
The reaction time was 2 h. Chromatography (5:95 to 12:88 EtOAc:petrol) gave 6b (213 
mg, 81%) as a pale yellow oil and as an inseparable mixture of diastereoisomers. 
Recrystallisation from hexane/EtOAc gave 6b as a single diastereoisomer, relative 
configuration confirmed by x-ray crystallographic analysis; mp 116–118 °C; Rf 0.16 
(20:80 EtOAc:petrol); max (film) 3080, 3059, 3028, 1738, 1637, 1608, 1597, 1512, 1495, 
1448, 1377, 1323, 1306, 1279, 1259, 1178, 1142, 1084, 1032, 966, 918, 862, 816, 779, 
729, 708, 692, 668, 650 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 2.38 (3H, s, Ts-
CH3), 3.62 (3H, s, Ar-OCH3), 4.05 (dd, 
3
JH,H = 11.5, 8.5 Hz, 1H, MeO-C6H4-CH<), 4.28 
(ddd, 
3
JH,H = 12.5, 7.0 Hz, 
4
JH,H =1.0 Hz, 1H, -CHHO-), 4.37 (ddd, 
3
JH,H = 12.5, 7.0 Hz, 
4
JH,H =1.0 Hz, 1H, -CHHO-), 4.46 (d, 
3
JH,H = 11.5 Hz, 1H, -OCO-C(H)Ts-), 5.13 (d, 
3
JH,H 
= 17.5 Hz, 1H, trans -CH=CH2), 5.16 (d, 
3
JH,H = 9.5 Hz, 1H, cis -CH=CH2), 5.66 (dt, 
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3
JH,H = 16.0, 7.0 Hz, 1H, Ph-CH=CH-), 6.17 (ddd, 
3
JH,H = 18.0, 9.0, 7.5 Hz, 1H, 
-CH=CH2), 6.33 (d, 
3
JH,H = 16.0 Hz, 1H, Ph-CH=), 6.73 (dt, 
3
JH,H = 9.5, 2.5 Hz, 2H, o-
MeOAr), 7.06 (dt, 
3
JH,H = 9.5, 2.5 Hz, 2H, m-MeOAr), 7.23-7.34 (m, 7H, other Ar-H), 
7.80 (d, 
3
JH,H = 8.5 Hz, 2H, o-SO2Ar); 
13
C NMR (100 MHz, CDCl3, 25°C): δ = 21.7 (Ts-
CH3), 48.4 (MeO-C6H4-CH<), 55.1 (Ar-OCH3), 66.3 (-CH2O-), 75.6 (-OCO-C(Ts)H-), 
114.2 (3° MeOAr), 117.7 (=CH2), 121.7 (Ph-CH=CH-), [126.6, 128.2, 128.6] (3° Ph), 
129.1 (3° MeOAr), 129.5 (3° -SO2Ar), 129.7 (3° -SO2Ar), 131.1 (4° MeOAr), 134.8 (Ph-
CH=), 135.0 (4° -SO2Ar), 135.9 (4° Ph), 137.1 (-CH=CH2), 145.4 (4° -SO2Ar), 158.8 (4° 
MeOAr), 165.0 (C=O); m/z (CI) 494 [M+NH4]
+
, 450, 340, 334, 279, 224, 174, 161, 147, 
134  [C9H10O]
+
, 117 [C9H9]
+
, 101 (Found: [M+NH4]
+
, 494.1983. C28H28O5S requires 
[M+NH4]
+
, 494.2001).  
 
 
Cinnamyl (E)-2-(toluene-4-sulfonyl)-3-vinylhex-4-enoate (6c): (±)-
(cinnamyl)((2E,4E)-hexa-2,4-dienyl)-2-(toluene-4-sulfonyl)malonate 5c (567 mg, 1.25 
mmol), potassium acetate (12 mg, 0.13 mmol) and N,O-bis(trimethylsilyl)acetamide (300 
µl, 1.25 mmol) were employed in general procedure 4. Chromatography (15:85 
EtOAc:petrol) gave 6c (407 mg, 79%) as a pale yellow oil and as an inseparable mixture 
of diastereoisomers; Rf 0.31 (20:80 EtOAc:petrol); max (film) 3028, 3060, 3028, 1739, 
1637, 1597, 1495, 1448, 1379, 1325, 1306, 1213, 1146, 1084, 966, 924, 847, 816, 744, 
708, 694, 660 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ = [1.56, 1.67] (dd, 
3
JH,H = 6.5 
Hz, 
4
JH,H = 1.5 Hz, 3H, =CH-CH3, 2× diast.), [2.35, 2.36] (s, 3H, Ts-CH3, 2× diast.), 3.51-
3.62 (m, 1H, H3C-CH=CH-CH(CH=CH2)-, 2× diast.), 4.07 (d, 
3
JH,H = 9.5 Hz, 1H, -OCO-
CH(Ts)-, 2× diast.), [4.61 (ddd, 
3
JH,H = 6.5, 2.5 Hz, 
4
JH,H = 1.5 Hz), 4.64 (ddd 
3
JH,H = 6.5, 
1.0 Hz, 
4
JH,H = 1.0 Hz)] (2H, -CH2O-, 2× diast.), [5.04, 5.16] (dt, 
3
JH,H = 10.5 Hz, 
4
JH,H = 
1.0 Hz, 1H, cis -CH=CH2, 2× diast.), [5.09, 5.16] (dt, 
3
JH,H = 17.0 Hz, 
4
JH,H = 1.0 Hz, 1H, 
trans -CH=CH2, 2× diast.), [5.33 (ddq, 
3
JH,H = 15.5, 8.5 Hz, 
4
JH,H = 1.5 Hz), 5.38 (ddq, 
3
JH,H = 14.0, 7.5 Hz, 
4
JH,H = 1.5 Hz)] (1H, H3C-CH=CH-, 2× diast.), [5.53 (dqd, 
3
JH,H = 
15.0, 6.5 Hz, 
4
JH,H =1.0 Hz), 5.58 (dqd, 
3
JH,H = 14.5, 6.5 Hz, 
4
JH,H = 1.0 Hz)] (1H, H3C-
CH=, 2× diast.), [5.73, 5.90] (ddd, 
3
JH,H = 17.5, 10.0, 7.5 Hz, 1H, H2C=CH-, 2× diast.), 
[6.05, 6.08] (dt, 
3
JH,H = 16.0, 6.5 Hz, 1H, Ph-CH=CH-, 2× diast.), [6.57, 6.58] (dt, 
3
JH,H = 
16.0 Hz, 
4
JH,H = 1.5 Hz, 1H, Ph-CH=, 2× diast.), 7.25-7.36 (m, 7H, other Ar-H), [7.75, 
7.76] (dd, 
3
JH,H = 8.5 Hz, 
4
JH,H = 2.0 Hz, 2H, o-SO2Ar, 2× diast.); 
13
C NMR (75 MHz, 
CDCl3, 25°C): δ = [18.1, 18.0] (=CH-CH3, 2× diast.), 21.7 (Ts-CH3, 2× diast.), 46.3 
(H3C-CH=CH-CH(CH=CH2)-, 2× diast.), 46.3 (H3C-CH=CH-CH(CH=CH2)-, 2× diast.), 
[66.4, 66.5] (-CH2O-, 2× diast.), [74.3, 74.4] (-OCO-CH(Ts)-, 2× diast.), 117.4, 117.5, 
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121.9, 126.7, 127.4, 128.0, 128.3 (×2), 128.7, 129.2, 129.3, 129.4, 129.5, 129.6, 135.1, 
135.2, 135.6, 135.7, 136.0, 136.2, 145.2, 145.3, 165.2 (C=O); m/z (CI) 428 [M+NH4]
+
, 
268, 255, 197, 174, 156, 139, 134 [C9H10O]
+
, 117 [C9H9]
+
, 95 (Found: [M+NH4]
+
, 
428.1897. C24H26O4S requires [M+NH4]
+
, 428.1896). 
 
 
(E)-Pent-2-enyl 3-phenyl-2-(toluene-4-sulfonyl)pent-4-enoate, (6d) and Cinnamyl 3-
ethyl-2-(toluene-4-sulfonyl)pent-4-enoate (6d’):  (±)-(cinnamyl)((2E)-pent-2-enyl)-2-
(toluene-4-sulfonyl)malonate 5d (250 mg, 0.565 mmol), potassium acetate (5 mg, 0.06 
mmol), and N,O-bis(trimethylsilyl)acetamide  (0.275ml, 1.13 mmol) were used in general 
procedure 4, with the following additions: The solvent was PhMe (5 mL), the reaction 
temperature was 55 °C and the reaction time was 4 h. Chromatography (15:85 
EtOAc:petrol) gave 6d and 6d’ (190 mg total, 84%) as a yellow oil and as an inseparable 
mixture of regio- and diastereoisomers. 6d was the major regioisomer in a ratio 6d:6d’ 
3:1; Rf 0.34 (20% EtOAc–petrol); max (film) 3082, 3062, 3030, 1739, 1671, 1639, 1597, 
1493, 1454, 1415, 1401, 1379, 1327, 1306, 1279, 1205, 1182, 1146, 1084, 1018, 970, 
926, 814, 760, 746, 702, 663 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = 0.80-1.05 (m, 
3H, -CH2CH3), 1.11-1.59 (m, 2H, H3C-CH2, 2× diast. of 6d’), [1.93, 2.09] (t, 
3
JH,H = 7.0 
Hz, 2H, H3C-CH2-, 2× diast. of 6d), [2.33, 2.35, 2.38, 2.46] (s, 3H, Ts-CH3 for 2× diast. 
each of 6d’, 6d), 2.75-2.89 (m, 1H, H3C-CH2-CH< for 6d’), 3.49-3.72 (m, 1H, SO2CH< 
for 6d’), 4.00-4.24 (m, 2H, -SO2CH<, Ph-CH< for 6d), [4.50, 4.54, 4.68] (d, 
3
JH,H = 6.5 
Hz, 2H, -OCH2- for 6d’, 6d), 4.92-6.25 (m, 5H, olefinic 6d’, 6d), [6.54, 6.60] (d, 
3
JH,H = 
16.5 Hz, 1H for 6d’, Ph-CH=, 2× diast. of 6d’), 7.11-7.42 (m, 7H, other Ar-H), 7.78-7.84 
(m, 2H, o-SO2Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = [11.0, 11.2] (H3C-CH2- for 2× 
diast. of 6d’), [13.0, 13.1] (H3C-CH2- for 2× diast. of 6d), [21.6, 21.7] (Ts-CH3), [25.2, 
25.3] (H3C-CH2-), [44.6, 44.8] (H3C-CH2-CH< for 2× diast. of 6d’), [49.3, 49.3] (Ph-
CH< for 2× diast. of 6d), [66.3, 66.5, 67.0] (-CH2O-), [74.3, 74.9, 75.0, 75.1] (-SO2CH< 
for 2× diast. of 6d’, 6d), 117.8, 117.9, 118.5, 118.9, 121.5, 121.9, 126.7, 127.3, 127.4, 
128.0, 128.3, 128.4, 128.6, 128.7, 128.8, 129.3, 129.5, 129.6, 129.8, 135.1, 135.3, 135.5, 
136.0, 136.0, 136.5, 136.6, 136.9, 138.0, 138.5, 139.1, 139.3, [144.6, 145.2, 145.3, 145.4] 
(4° -SO2Ar for 2× diast. of 6d’, 6d), [164.9, 165.0, 165.3, 165.7] (C=O for 2× diast. of 
6d’, 6d); m/z (CI) 416 [M+NH4]
+
, 372 [M+NH4-CO2]
+
, 348, 316, 304, 262, 256, 237 
(Found: [M+NH4]
+
, 416.1896. C23H26O4S requires [M+NH4]
+
, 416.1896). 
 
 
 40 
Allyl 3-phenyl-2-(toluene-4-sulfonyl)pent-4-enoate (6e): (±)-(allyl)(cinnamyl)-2-
(toluene-4-sulfonyl)malonate 5e (1.14 g, 2.76 mmol), potassium acetate (27 mg, 0.28 
mmol) and N,O-bis(trimethylsilyl)acetamide (1.34 mL, 5.52 mmol, 2.0 equiv) were used 
in general procedure 4, with the following additions: The solvent was PhMe (55 mL), the 
reaction temperature was 110 °C and the reaction time was 16 h. Chromatography 
(2:98→12.5:87.5 EtOAc:petrol) gave 6e (670 mg, 66%) as a pale yellow oil and as an 
inseparable mixture of diastereoisomers; Rf 0.26 (20% EtOAc–petrol); max (film) 3084, 
3062, 3030, 1741, 1639, 1597, 1493, 1454, 1327, 1290, 1279, 1205, 1146, 1084, 989, 
928, 858, 816, 760, 744, 702, 665 cm
-1
; 
1
H NMR (300 MHz, CDCl3, 25°C): δ = [2.39 
(min. diast.), 2.48 (maj. diast.)] (s, 3H, Ts-CH3, 2× diast.), [4.01-4.24, 4.49-4.65] (m, 4H, 
-OCH2-, -SO2CH<, H2C=CH-C(Ph)H-, 2× diast.), 4.95-5.42 (m, 4H, both -CH=CH2, 2× 
diast.), 5.81-5.97 (m, 1H, H2C=CH-C(Ph)H-, 2× diast.), 6.13-6.24 (m, 1H, H2C=CH-
CH2-, 2× diast.), 7.11-7.41 (m, 7H, other Ar-H), [7.77 (min. diast.), 7.83 (maj. diast.)] (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2Ar); 
13
C NMR (75 MHz, CDCl3, 25°C): δ = [22.0, 22.1] (Ts-
CH3, 2× diast.), [49.7, 49.8] (H2C=CH-C(Ph)H-, 2× diast.), [66.7, 67.2] (-OCH2-, 2× 
diast.), [75.3, 75.8] (-SO2CH<, 2× diast.), 118.2 (2°), 118.4 (2°), 119.3 (2°),  119.5 (2°), 
119.6 (2°),  119.8 (2°), 127.1 (3°), 127.7 (3°), 127.9 (3°), 128.4 (3°), 128.8 (3°), 129.0 
(3°), 129.1 (3°), 129.2 (3°), 129.8 (×2) (3°), 129.9 (3°), 130.2 (3°), 131.1 (3°), 131.4 (3°), 
131.5 (3°), 132.1 (3°), 135.3 (4°), 136.4 (4°), 137.0 (3°), 137.1 (3°), 138.2 (4°), 139.6 
(4°), 145.0 (4°), 145.9 (4°), [165.2, 165.3] (C=O, 2× diast.); m/z (CI) 388 [M+NH4]
+
, 
312, 214, 174, 61, 44 (Found: [M+NH4]
+
, 388.1576. C21H22O4S requires [M+NH4]
+
, 
388.1583) (Found: C, 67.97; H, 5.86. C21H22O4S requires C, 68.08; H, 5.99%). 
 
 
 (E)-5-(Trimethylsilyl)pent-2-en-4-ynyl 3-phenyl-2-(toluene-4-sulfonyl)pent-4-enoate 
(6f): (±)-(cinnamyl)(5-trimethylsilanylpent-2-en-4-ynyl)-2-(toluene-4-sulfonyl)malonate 
5f (143 mg, 0.279 mmol, 1.0 equiv), potassium acetate (3 mg, 0.028 mmol, 0.1 equiv) 
and N,O-bis(trimethylsilyl)acetamide (70 μL, 0.279 mmol, 1.0 equiv) were used in 
general procedure 4. Chromatography (20:80 EtOAc:petrol) gave 6f (102 mg, 82%) as a 
yellow oil and as an inseparable mixture of diastereoisomers; Rf 0.32 (20% EtOAc–
petrol); max (film) 3064, 3032, 2179, 2135, 1743, 1637, 1597, 1493, 1454, 1406, 1377, 
1329, 1306, 1277, 1252, 1205, 1184, 1146, 1084, 987, 951, 926, 847, 760, 739, 702, 654 
cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 0.20 (s, 9H, -Si(CH3)3), [2.37, 2.46] (s, 3H, 
Ts-CH3), 4.05-4.22 (m, 1H + 2H for 1
st
 diast., Ph-CH< for 2× diast., -OCH2- for 1
st
 
diast.), [4.47 (d, 
3
JH,H = 8.0 Hz), 4.49 (d, 
3
JH,H = 7.0 Hz)] (1H, -SO2-CH<, 2× diast.), 4.60 
(d, 
3
JH,H = 6.0 Hz, 2H for 2
nd
 diast., -OCH2-), 5.05-5.195 (m, 2H, -CH=CH2), [5.29 (1
st
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diast.), 5.73 (2
nd
 diast.)] (d, 
3
JH,H = 16.0 Hz, 1H, -OCH2-CH=CH-), [5.54 (1
st
 diast.), 6.07 
(2
nd
 diast.)] (dt, 
3
JH,H = 16.0, 6.0 Hz, 1H, -OCH2-CH=), [5.89 (ddd, 
3
JH,H = 18.0, 9.0, 8.0 
Hz, 1
st
 diast.), 6.18 (ddd, 
3
JH,H = 18.0, 9.0, 7.5 Hz, 2
nd
 diast.)] (1H, H2C=CH-), [7.08-7.38 
(m, other Ar-H), 7.79 (d, 
3
JH,H = 8.0 Hz, o-SO2Ar for 1 diast.)] (9H); 
13
C NMR (75 MHz, 
CDCl3, 25°C): δ = –0.2 (-Si(CH3)3) , [21.8, 21.7] (Ts-CH3), [49.3, 49.3] (Ph-CH<), [64.9 
(1
st
 diast), 65.4 (2
nd
 diast.)] (-OCH2-), [74.8, 75.3] (-SO2CH<), [96.6, 96.7] (-OCH2-
CH=CH-C≡C-), 102.2 (-OCH2-CH=CH-C≡), [113.8 (1
st
 diast.), 114.3 (2
nd
 diast.)] 
(-OCH2-CH=CH-), [118.1, 117.9] (-CH=CH2) , 127.4 (3°), 127.7 (3°), 127.9 (3°), 128.3 
(3°), 128.6 (3°), 128.7 (3°), 128.9 (3°), 129.4 (3°), 129.6 (3°), 129.7 (3°), [134.8, 135.8] 
(i-SO2Ar) [135.6 (1
st
 diast.), 136.0 (2
nd
 diast.)] (-OCH2-CH=), [136.4 (1
st
 diast.), 136.6 
(2
nd
 diast.)] (H2C=CH-), [137.8, 139.0] (i-Ph), [144.8, 145.6] (p-SO2Ar), 164.7 (×2, 
C=O); m/z (CI) 484 [M+NH4]
+
, 467 [M+H]
+
, 311, 182, 157, 141, 117, 91 (Found: 
[M+NH4]
+
, 484.1966. C26H30O4SSi requires [M+NH4]
+
, 484.1978).  
 
p-Nitrocinnamyl 3-phenyl-2-(toluene-4-sulfonyl)pent-4-enoate (6g) and Cinnamyl 3-
(4-nitrophenyl)-2-(toluene-4-sulfonyl)pent-4-enoate (6g’): (±)-1-cinnamyl 3-(E)-3-(4-
nitrophenyl)allyl 2-(toluene-4-sulfonyl)malonate  5g (255 mg, 0.476 mmol), potassium 
acetate (5 mg, 0.048 mmol) and N,O-bis(trimethylsilyl)acetamide (116 μL, 0.476 mmol, 
1.0 equiv) were used in general procedure 4. Chromatography (30:70 EtOAc:petrol) gave 
6g and 6g’ (67 mg total, 29%) as a yellow gum and as an inseparable mixture of regio- 
and diastereoisomers. 6g was the major regioisomer in a ratio 6g:6g’ 3:1; Rf 0.44 (30% 
EtOAc–petrol); max (film) 3064, 3030, 3007, 1741, 1597, 1518, 1493, 1454, 1377, 1344, 
1327, 1304, 1290, 1205, 1184, 1146, 1111, 1084, 1016, 972, 914, 860, 814, 733, 702, 
665, 650 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 25°C): δ = [2.36, 2.37, 2.44, 2.46] (s, 3H, Ts-
CH3), [4.06 (dd, 
3
JH,H = 11.0, 4.0 Hz), 4.25-4.12 (m)] (1H, Ts-CH-CH<), [4.54 (d, 
3
JH,H = 
4.0 Hz), 4.57 (d, 
3
JH,H = 3.5 Hz), 4.59 (d, 
3
JH,H = 4.0 Hz)] (1H, Ts-CH<), [4.35 (dd, 
2
JH,H 
= 13.5 Hz, 
3
JH,H = 6.0 Hz), 4.45 (dd, 
2
JH,H = 13.5 Hz, 
3
JH,H = 6.0 Hz), 4.93-4.74 (m)] (2H, 
-OCH2-), 5.15 (1H, d, 
3
JH,H = 17.0 Hz, trans -CH=CH2), [5.06 (d, 
3
JH,H = 10.0 Hz), 5.18 
(d, 
3
JH,H = 9.5 Hz)] (1H, cis -CH=CH2), [5.36-5.344 5.79-5.91, 5.97-5.99] (m, 1H, 
NO2Ar-CH=CH- and Ph-CH=CH-), [5.91-5.94], 6.08-6.20 (m, 1H, -CH=CH2), 6.42 (d, 
3
JH,H = 16.0 Hz, 1H 6g maj. diast. and 6g’ min. diast., NO2Ar-CH= and Ph-CH=), 6.44 
(d, 
3
JH,H = 16.0 Hz, 1H 6g’ maj. diast., Ph-CH=), 6.79 (d, 
3
JH,H = 16.0 Hz, 1H 6g min. 
diast., NO2Ar-CH=), [7.08-7.44 (m), 7.54 (d, 
3
JH,H = 8.5 Hz), 7.84 (d, 
3
JH,H = 8.0 Hz)] 
(11H, o-SO2Ar, m-NO2Ar, m-SO2Ar, Ph-H), [8.20, 8.22] (d, 
3
JH,H = 8.5 Hz, 2H, 
o-NO2Ar);
 13
C NMR (75 MHz, CDCl3, 25°C): δ = 21.6, 21.8, 22.7, 29.7, 49.4, 49.5, 62.0, 
62.5, 65.4, 65.9, 75.0, 75.3, 77.3, 117.8, 118.2, 123.7, 123.8, 123.9, 124.1, 124.3, 126.7, 
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127.0, 127.2, 127.3, 127.4, 127.5, 128.0, 128.4, 128.6, 128.7, 128.9 (×2) , 129.4, 129.6, 
129.8, 131.5, 131.8, 132.0, 132.2, 134.9, 136.0, 136.6 (×2) , 137.6, 139.2, 139.3, 142.1, 
142.3, 142.4, 142.5, 144.7, 145.6, 147.3, 164.9; m/z (CI) 509 [M+NH4]
+
, 437, 419, 293, 
236, 219 (Found: [M+NH4]
+
, 509.1748. C27H25NO6S requires [M+NH4]
+
, 509.1746).  
 
 
(±)-(E)-5-(Trimethylsilyl)pent-2-en-4-ynyl 2-(toluene-4-sulfonyl)pent-4-enoate (6h): 
(±)-(Allyl)(5-(trimethylsilyl)pent-2-en-4-yn-1-yl)-2-(toluene-4-sulfonyl) malonate 6h (43 
mg, 0.099 mmol), potassium acetate (1 mg, 0.001 mmol) and N,O-
bis(trimethylsilyl)acetamide (49 µL, 0.198 mmol, 2.0 equiv) were used in general 
procedure 4, with the following additions: The reaction was performed under conditions 
of microwave acceleration, the reaction temperature was 130 °C and the reaction time 
was 5 min. Chromatography (10:90 EtOAc:hexane) gave 6h (10 mg, 26%) as a 
colourless oil; Rf 0.24 (10% EtOAc-hexane); max (film) 2136, 1743, 1643, 1597, 1440, 
1376, 1328, 1305, 1250, 1169, 1147, 1084, 951, 924, 843, 814, 760 cm
-1
; 
1
H NMR (400 
MHz, CDCl3, 25°C): δ = 0.19 (s, 9H, -Si(CH3)3), 2.46 (s, 3H, Ts-CH3), 2.69 (ddd, 
2
JH,H = 
14.0 Hz, 
3
JH,H = 11.5, 7.5 Hz, 1H, H2C=CH-CHH-), 2.78-2.85 (m, 1H, H2C=CH-CHH-), 
3.98 (dd, 
3
JH,H = 11.5, 4.0 Hz, 1H, -OC(O)-CH(Ts)-), 4.51 (ddd, 
2
JH,H = 13.0 Hz, 
3
JH,H = 
5.0, 2.0 Hz, 1H, -CHHO-),  4.56 (ddd, 
2
JH,H = 13.0 Hz, 
3
JH,H = 5.0, 1.5 Hz, 1H, -CHHO-), 
5.09 (dd, 
3
JH,H = 10.0 Hz, 
4
JH,H = 1.0 Hz, 1H, cis -CH=CH2), 5.11 (dd, 
3
JH,H = 17.0 Hz, 
4
JH,H = 1.5 Hz, 1H, trans -CH=CH2), 5.62 (d, 
3
JH,H = 16.0 Hz, 1H, ≡C-CH=CH-), 5.60-
5.71 (m, 1H, H2C=CH-), 5.97 (dt, 
3
JH,H = 16.0, 6.0 Hz, 1H, ≡C-CH=CH-), 7.36 (d, 
3
JH,H 
= 8.0 Hz, 2H, m-SO2Ar), 7.73 (d, 
3
JH,H = 8.0 Hz, 2H, o-SO2Ar); 
13
C NMR (75 MHz, 
CDCl3, 25°C): δ = –0.2 (-Si(CH3)3), 21.7 (Ts-CH3), 30.8 (H2C=CH-CH2-), 65.2 
(-CH2O-), 70.1 (-OCO-CH(Ts)-) , 96.9 (Me3Si-C≡), 102.0 (Me3Si-C≡C-), 114.4 (3°), 
119.2 (=CH2) , 129.4 (3°), 129.8 (3°), 131.7 (3°), 134.0 (4°), 135.8 (3°), 145.6 (4°), 165.0 
(C=O); m/z (CI) 413 [M+Na]
+
, 391 [M+H]
+
, 235, 137 (Found: 413.1211. C20H26O4SSi 
requires [M+Na]
+
 413.1213).  
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